| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Atypical clinical manifestations of hepatitis A
|
Schiff, Eugene R.
|
|
1992
|
10 |
S1 |
p. S18-S20
3 p.
|
article
|
| 2 |
Clinical and laboratory observations following oral or intramuscular administration of a live attenuated hepatitis A vaccine candidate
|
Sjogren, Maria H.
|
|
1992
|
10 |
S1 |
p. S135-S137
3 p.
|
article
|
| 3 |
Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings
|
André, F.E.
|
|
1992
|
10 |
S1 |
p. S160-S168
9 p.
|
article
|
| 4 |
Clinical manifestations and diagnosis of hepatitis A virus infection
|
Koff, Raymond S.
|
|
1992
|
10 |
S1 |
p. S15-S17
3 p.
|
article
|
| 5 |
Cost-effectiveness analysis of hepatitis A prevention in travellers
|
Tormans, Guy
|
|
1992
|
10 |
S1 |
p. S88-S92
5 p.
|
article
|
| 6 |
Ecology and prevention of a shellfish-associated hepatitis A epidemic in Shanghai, China
|
Xu, Zhi-Yi
|
|
1992
|
10 |
S1 |
p. S67-S68
2 p.
|
article
|
| 7 |
Editorial
|
Spier, R.E.
|
|
1992
|
10 |
S1 |
p. S5-
1 p.
|
article
|
| 8 |
Editorial Board
|
|
|
1992
|
10 |
S1 |
p. IFC-
1 p.
|
article
|
| 9 |
Effect of hepatitis A vaccination schedules on immune response
|
Tilzey, Anthea J.
|
|
1992
|
10 |
S1 |
p. S121-S123
3 p.
|
article
|
| 10 |
Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine
|
Goubau, Patrick
|
|
1992
|
10 |
S1 |
p. S114-S118
5 p.
|
article
|
| 11 |
Epidemiological patterns of hepatitis A in different parts of the world
|
Gust, Ian D.
|
|
1992
|
10 |
S1 |
p. S56-S58
3 p.
|
article
|
| 12 |
Epidemiology of hepatitis A: Discussion
|
|
|
1992
|
10 |
S1 |
p. S97-S98
2 p.
|
article
|
| 13 |
Epidemiology of hepatitis A in Mediterranean countries
|
Papaevangelou, George
|
|
1992
|
10 |
S1 |
p. S63-S66
4 p.
|
article
|
| 14 |
Epidemiology of hepatitis A: seroepidemiology and risk groups in the USA
|
Shapiro, Craig N.
|
|
1992
|
10 |
S1 |
p. S59-S62
4 p.
|
article
|
| 15 |
Field efficacy trial of inactivated hepatitis A vaccine among children in Thailand (an extended abstract)
|
Innis, Bruce L.
|
|
1992
|
10 |
S1 |
p. S159-
1 p.
|
article
|
| 16 |
Field evaluation of a hepatitis A vaccine in a Norwegian contingent to the United Nations Interim Force in Lebanon
|
Aarhaug, Per
|
|
1992
|
10 |
S1 |
p. S156-S158
3 p.
|
article
|
| 17 |
Genetic, antigenic and biological differences between strains of hepatitis A virus
|
Lemon, Stanley M.
|
|
1992
|
10 |
S1 |
p. S40-S44
5 p.
|
article
|
| 18 |
Hepatitis A as an occupational hazard
|
Hofmann, Friedrich
|
|
1992
|
10 |
S1 |
p. S82-S84
3 p.
|
article
|
| 19 |
Hepatitis A in Norwegian troops
|
Hesla, Per Egil
|
|
1992
|
10 |
S1 |
p. S80-S81
2 p.
|
article
|
| 20 |
Hepatitis A in Swedish travellers
|
Nordenfelt, Erik
|
|
1992
|
10 |
S1 |
p. S73-S74
2 p.
|
article
|
| 21 |
Hepatitis A in the US Army: epidemiology and vaccine development
|
Hoke Jr, C.H.
|
|
1992
|
10 |
S1 |
p. S75-S79
5 p.
|
article
|
| 22 |
Hepatitis A vaccination: Schedule for accelerated immunization
|
Müller, R.
|
|
1992
|
10 |
S1 |
p. S124-S125
2 p.
|
article
|
| 23 |
Hepatitis A vaccine: development, safety and immunogenicty: Discussion
|
|
|
1992
|
10 |
S1 |
p. S146-S147
2 p.
|
article
|
| 24 |
How an outbreak of hepatitis A in Melbourne led to the development of a vaccine
|
Gust, Ian D.
|
|
1992
|
10 |
S1 |
p. S9-
1 p.
|
article
|
| 25 |
Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees
|
Purcell, Robert H.
|
|
1992
|
10 |
S1 |
p. S148-S151
4 p.
|
article
|
| 26 |
Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals
|
Davidson, Morton
|
|
1992
|
10 |
S1 |
p. S119-S120
2 p.
|
article
|
| 27 |
Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine
|
Binn, L.N.
|
|
1992
|
10 |
S1 |
p. S102-S105
4 p.
|
article
|
| 28 |
Management of acute and fulminant hepatitis A
|
O'Grady, John
|
|
1992
|
10 |
S1 |
p. S21-S23
3 p.
|
article
|
| 29 |
Molecular basis of virulence and growth of hepatitis A virus in cell culture
|
Emerson, Suzanne U.
|
|
1992
|
10 |
S1 |
p. S36-S39
4 p.
|
article
|
| 30 |
Natural hosts of hepatitis A virus
|
Balayan, Mikhail S.
|
|
1992
|
10 |
S1 |
p. S27-S31
5 p.
|
article
|
| 31 |
Passive immunization against hepatitis A
|
Stapleton, Jack T.
|
|
1992
|
10 |
S1 |
p. S45-S47
3 p.
|
article
|
| 32 |
Persistence of vaccine-induced antibody to hepatitis A virus
|
Wiedermann, G.
|
|
1992
|
10 |
S1 |
p. S129-S131
3 p.
|
article
|
| 33 |
Perspectives on the control of hepatitis A by vaccination
|
Kane, Mark A.
|
|
1992
|
10 |
S1 |
p. S93-S96
4 p.
|
article
|
| 34 |
Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile
|
Riedemann, S.
|
|
1992
|
10 |
S1 |
p. S152-S155
4 p.
|
article
|
| 35 |
Possible approaches to develop vaccines against hepatitis A
|
D'Hondt, Erik
|
|
1992
|
10 |
S1 |
p. S48-S52
5 p.
|
article
|
| 36 |
Preface
|
Hollinger, F.Blaine
|
|
1992
|
10 |
S1 |
p. S6-S7
2 p.
|
article
|
| 37 |
Presentation to Dr F. MacCallum
|
|
|
1992
|
10 |
S1 |
p. S8-
1 p.
|
article
|
| 38 |
Prevention of viral hepatitis A: past, present and future
|
Deinhardt, Friedrich
|
|
1992
|
10 |
S1 |
p. S10-S14
5 p.
|
article
|
| 39 |
Production, quality control and characterization of an inactivated hepatitis A vaccine
|
Peetermans, Julien
|
|
1992
|
10 |
S1 |
p. S99-S101
3 p.
|
article
|
| 40 |
Properties and classification of hepatitis A virus
|
Melnick, Joseph L.
|
|
1992
|
10 |
S1 |
p. S24-S26
3 p.
|
article
|
| 41 |
Prospects for control of hepatitis A: Panel discussion
|
|
|
1992
|
10 |
S1 |
p. S170-S174
5 p.
|
article
|
| 42 |
Protective efficacy trials: Discussion
|
|
|
1992
|
10 |
S1 |
p. S169-
1 p.
|
article
|
| 43 |
Reactogenicity and immunogenicity of inactivated hepatitis A vaccines
|
Just, Max
|
|
1992
|
10 |
S1 |
p. S110-S113
4 p.
|
article
|
| 44 |
Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine
|
Theilmann, L.
|
|
1992
|
10 |
S1 |
p. S132-S134
3 p.
|
article
|
| 45 |
Replication of hepatitis A virus and processing of proteins
|
Siegl, Günter
|
|
1992
|
10 |
S1 |
p. S32-S35
4 p.
|
article
|
| 46 |
Risk of hepatitis A in travellers
|
Steffen, Robert
|
|
1992
|
10 |
S1 |
p. S69-S72
4 p.
|
article
|
| 47 |
Serological approaches to distinguish immune response to hepatitis A vaccine and natural infection
|
Robertson, Betty H.
|
|
1992
|
10 |
S1 |
p. S106-S109
4 p.
|
article
|
| 48 |
Simultaneous passive and active immunization against hepatitis A
|
Leentvaar-Kuijpers, A.
|
|
1992
|
10 |
S1 |
p. S138-S141
4 p.
|
article
|
| 49 |
Simultaneous vaccination against hepatitis A and B: results of a controlled study
|
Ambrosch, F.
|
|
1992
|
10 |
S1 |
p. S142-S145
4 p.
|
article
|
| 50 |
Vaccination against hepatitis A: comparison of different short-term immunization schedules
|
Jilg, Wolfgang
|
|
1992
|
10 |
S1 |
p. S126-S128
3 p.
|
article
|
| 51 |
Virology and clinical aspects of hepatitis A: Discussion
|
|
|
1992
|
10 |
S1 |
p. S53-S55
3 p.
|
article
|
| 52 |
Who should receive hepatitis A vaccine? Considerations for the development of an immunization strategy
|
Margolis, Harold S.
|
|
1992
|
10 |
S1 |
p. S85-S87
3 p.
|
article
|
Journal description